Ablative Solutions

Wakefield, MA · Founded 2011 · Privately Held (backing)

Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension. Ablative Solutions is based in Wakefield, MA and was founded in 2011. Its last reported valuation was $140 million in Jun 2022. It has raised $215 million across 4 recorded rounds; the latest was a $10.4 million early-stage round in Nov 2025.

Last reported valuation
$140.0M
Oct 2026
Priced at
—
Total raised
$214.6M
Last round
Early Stage VC
Nov 2025

Who backs Ablative Solutions?

11 investors
InvestorType
Invus OpportunitiesVenture capital
Gilde HealthcarePE / buyout
BioStar Capital—
CKM Capital—
Charter Private Capital Management—
Dempsey Ventures—
Grand Angels—
Jason Balk—
Michigan Capital Network—
Open Prairie Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ablative Solutions investors

11 investors are on record for Ablative Solutions, including Invus Opportunities, Gilde Healthcare, BioStar Capital and CKM Capital. The early-stage round in Nov 2025 drew 10 investors.

Free account
More of Ablative Solutions with a free account
  • ·The complete investor list: 11 names
  • ·Watch Ablative Solutions: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Ablative Solutions. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View